SciELO - Scientific Electronic Library Online

 
vol.25 issue4Diagnosis and multidisciplinary treatment of early-stage and locally advanced melanoma: Expert consensus, Colombian Association of Hemato-Oncology (ACHO)Primary rectal Hodgkin's lymphoma and synchronous small bowel neuroendocrine tumor: Case report and literature review author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Cancerología

Print version ISSN 0123-9015

Abstract

FRANCO, Oscar A.  and  OLAYA, Natalia. Clonal hematopoiesis of indeterminate potential (CHIP): Beyond a model of field cancerization. rev.colomb.cancerol. [online]. 2021, vol.25, n.4, pp.210-221.  Epub June 04, 2022. ISSN 0123-9015.  https://doi.org/10.35509/01239015.726.

Clonal hematopoiesis of indeterminate potential (CHIP) is the expansion of hematopoietic stem cells harboring one or more somatic mutations. These patients do not have underlying hematologic neoplasia, myelodysplasia, or dysplasia, but can progress to a malignant state at a rate of 0.5 to 1% per year. CHIP could be used as a model of field cancerization, since it has been associated with chronic inflammatory diseases, arteriosclerosis, diabetes, and autoimmune conditions. CHIP is also considered a predictive factor in hematological and non-hematological cancer patients receiving chemotherapy and radiotherapy.

Keywords : clonal hematopoiesis; clonal expansion; field cancerization; chemotherapy; therapy-related myeloid neoplasm; somatic mutation; inflammation; aging.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )